top of page

Biotech investor Thilo Schroeder of Nextech Invest shares his take on biotech and discusses portfolio companies Revolution Medicines, Tubulis, and Circle Pharma

May 2, 2025

1 min read

He describes the history of Nextech, including being an early investor in Blueprint Medicines and Peloton Therapeutics, and discusses the importance of investing in companies that have a wide moat to protect from today's fierce global competition.

https://vimeo.com/1080868000?share=copy

Recent Posts

See All

Stifel Research Analyst Alex Thompson shares his take on the state of the I&I space and highlights a few key companies

BIO-Europe 2026: KHAN, an early-stage investor based in Germany, works with academics to progress research projects, many of which turn into companies

Stifel's Head of Therapeutics Research Paul Matteis shares his take on biotech and discusses companies he covers that have been in the news

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Mispro is an AAALAC-accredited contract vivarium organization (CVO) offering a network of full-service vivarium rental lab facilities for preclinical in vivo rodent studies. Along with access to state-of-the-art lab spaces, Mispro supports its clients with comprehensive laboratory animal research services, including husbandry, veterinary, technical, and regulatory compliance oversight. With locations in all major U.S. biotech hubs, Mispro is committed to helping biosciences companies of all sizes and therapeutic indications achieve their research goals.

Learn more